Clinical Trials Logo

Filter by:
  • Active, not recruiting  
  • « Prev · Page [2]
NCT ID: NCT02794428 Active, not recruiting - Gastric Cancer Clinical Trials

Chemoprevention of Gastric Carcinogenesis

Start date: September 19, 2016
Phase: Phase 2
Study type: Interventional

A clinical study of the efficacy of oral alpha-difluoromethylornithine (eflornithine or DFMO) in male and female subjects ages 30-60 with gastric premalignant lesions in two high risk regions of Latin America.

NCT ID: NCT02782949 Active, not recruiting - Clinical trials for Chronic Atrophic Gastritis

Curcumin in Preventing Gastric Cancer in Patients With Chronic Atrophic Gastritis or Gastric Intestinal Metaplasia

Start date: April 4, 2017
Phase: Phase 2
Study type: Interventional

This randomized phase IIb trial studies how well curcumin works in preventing gastric cancer in patients with chronic atrophic gastritis and/or gastric intestinal metaplasia. Curcumin is an antioxidant compound found in plants that may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth.

NCT ID: NCT02246465 Active, not recruiting - Hypertrophic Scar Clinical Trials

A Study to Evaluate the Effectiveness and Safety of RXI 109 on the Outcome of Revised Hypertrophic Scars

Start date: July 2014
Phase: Phase 2
Study type: Interventional

The purpose of this study is to determine the effectiveness of RXI-109 in reducing the recurrence of hypertrophic scar formation following elective revision of a pre-existing hypertrophic scar.

NCT ID: NCT01881659 Active, not recruiting - Cervical Cancer Clinical Trials

Cervical Cancer Screening With Human Papillomavirus Testing

ESTAMPA
Start date: May 2013
Phase:
Study type: Observational

HPV testing for primary cervical cancer screening of women over 30 years of age is likely to become the standard of care in the near future in many areas of the world. Its high sensitivity can significantly improve the effectiveness of screening programs and its prolonged negative predictive value can allow extension of screening intervals. However, a single HPV test has low positive predictive value and can lead to unnecessary workup and over-treatment and generate unnecessary distress. This multi-centric study will screen 50,000 women with HPV testing and compare several triage approaches that can follow HPV testing in order to make an HPV-based screening programme efficient, affordable and sustainable.